According to Dr. Travis Berggren, Director of the Salk Institute for Biological Studies' Stem Cell Core Facility, "We are thrilled to have access to the LEAP Workstation to support our research. The Salk Stem Cell Core Facility is dedicated to research involving human pluripotent stem cells. The versatility of these stem cells holds great potential for creating new models to study human diseases and determining their underlying molecular mechanisms to allow the development of new therapies. The unique capabilities of the LEAP technology will enable us to work with these delicate cells in powerful new ways."

"We are excited by our relationship with the Salk Institute for Biological Studies and expect LEAP to fuel new and innovative stem cell research," said Dr. Fred Koller, Cyntellect's Chief Technology Officer. "Stem cell research has the potential to revolutionize how we think of disease treatment. The cutting edge research being undertaken by Salk scientists is the starting point to unlocking the true potential of stem cells, and we are proud to play a small supporting role."

SOURCE Salk Institute for Biological Studies